0.2503
Schlusskurs vom Vortag:
$0.245
Offen:
$0.2452
24-Stunden-Volumen:
173.46K
Relative Volume:
0.16
Marktkapitalisierung:
$4.72M
Einnahmen:
$5.54M
Nettoeinkommen (Verlust:
$-4.74M
KGV:
-0.7449
EPS:
-0.336
Netto-Cashflow:
$-750.60K
1W Leistung:
-5.12%
1M Leistung:
+19.25%
6M Leistung:
-2.61%
1J Leistung:
-32.97%
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Firmenname
China Pharma Holdings Inc.
Sektor
Telefon
86 898 6681 1730
Adresse
No. 17, Jinpan Road, Second Floor, Haikou
Vergleichen Sie CPHI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CPHI
China Pharma Holdings Inc.
|
0.2503 | 4.72M | 5.54M | -4.74M | -750.60K | -0.336 |
![]()
ZTS
Zoetis Inc
|
163.26 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.15 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.32 | 17.38B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
131.87 | 14.05B | 612.78M | -86.37M | -62.91M | -0.87 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2010-01-08 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten
China NT Pharma Reports Significant Losses for 2024 - TipRanks
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates - Yahoo Finance
Big pharma faces headwinds in China as vaccine sales decline - Yahoo
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025 - Yahoo Finance
China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com - Defense World
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update - Quantisnow
Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - Yahoo Finance
Hedge funds, pharma CEOs on list of attendees for China business summit - Yahoo Finance
Prefilled Syringes Market Hits New High | Major Giants Weigao Group, YPSOMED AG , Boditech Med Inc - Newstrail
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance
Is Zoetis Inc. (ZTS) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
SEC Form 10-K filed by Corbus Pharmaceuticals Holdings Inc. - Quantisnow
Is PDD Holdings Inc. (PDD) the Cheap Chinese Stock to Buy Now? - Insider Monkey
Aspen Pharmacare Holdings Ltd (APNHY) (H1 2025) Earnings Call Highlights: Strong Growth Amid ... - Yahoo Finance
Alliance Pharma And 2 Other UK Penny Stocks With Promising Fundamentals - Yahoo Finance
Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online
Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ... - Yahoo Finance
China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World
Can Euro Tech's $2.2M Water Treatment Deals Signal Growth in China's Environmental Tech Market? - StockTitan
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Here’s Why - Defense World
Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - The Manila Times
Allspring Global Investments Holdings LLC Decreases Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - The AM Reporter
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire
InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance
Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance
U.S. investors, Big Pharma race to find new medicines in China - MSN
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow
Hong Kong Stock Exchange Companies List - Morningstar.com.au
China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex
Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex
Big Pharma is staying quiet on Trump's China tariffs - Yahoo Finance
Wall Street Today: US stocks open flat amid China’s response to Trump tariffs; Nvidia up 3.19% - Mint
China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance
3 Leading Dividend Stocks Including Dawnrays Pharmaceutical Holdings - Simply Wall St
China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):